Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

Author： Nabholtz Jean-marc Gligorov Joseph

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.9, 2005-08, pp. : 1555-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trastuzumab-based combination therapy for breast cancer

By Montemurro Filippo Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 81-96

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab/docetaxel/platinum salts for advanced breast cancer

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Trastuzumab plus docetaxel in metastatic breast cancer

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Neoadjuvant docetaxel, vinorelbine and trastuzumab prior to surgery and adjuvant therapy is active in patients with HER-2 breast cancer

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Preoperative trastuzumab, docetaxel and carboplatin therapy is effective for HER2-positive breast cancer

Inpharma, Vol. 1, Iss. 1592, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite